We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$294B
AUM Growth
+$23.6B
Cap. Flow
+$7.38B
Cap. Flow %
2.51%
Top 10 Hldgs %
16.68%
Holding
4,142
New
98
Increased
2,556
Reduced
827
Closed
120

Sector Composition

Rank Sector Weight
1 Technology 16.85%
2 Financials 16.38%
3 Healthcare 13.22%
4 Industrials 10.47%
5 Consumer Discretionary 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLNG icon
3951
Stabilis Solutions
SLNG
$90.2M
$17K ﹤0.01%
1,450
AEY
3952
DELISTED
ADDvantage Technologies Group
AEY
$17K ﹤0.01%
1,193
ARGS
3953
DELISTED
Argos Therapeutics, Inc.
ARGS
$17K ﹤0.01%
5,750
-702
-11% -$2.35K
LTBR icon
3954
Lightbridge
LTBR
$258M
$16K ﹤0.01%
1,110
BYU
3955
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$15K ﹤0.01%
9
OTLK icon
3956
Outlook Therapeutics
OTLK
$191M
$14K ﹤0.01%
70
PHIO icon
3957
Phio Pharmaceuticals
PHIO
$11.5M
0
RKDA icon
3958
Arcadia Biosciences
RKDA
$1.44M
$14K ﹤0.01%
66
+33
+100% +$7.15K
AFMD
3959
DELISTED
Affimed
AFMD
$13K ﹤0.01%
1,000
-876
-47% -$16.6K
IMNP
3960
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$12K ﹤0.01%
22,355
TIO
3961
DELISTED
Tingo Group, Inc. Common Stock
TIO
$12K ﹤0.01%
11,589
IPCI
3962
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$11K ﹤0.01%
1,376
AIXC
3963
AIxCrypto Holdings Inc
AIXC
$14M
0
SEED icon
3964
Origin Agritech
SEED
$11.9M
$9K ﹤0.01%
1,062
JRJR
3965
DELISTED
JRjr33, Inc.
JRJR
$8K ﹤0.01%
44,389
PGH
3966
DELISTED
Pengrowth Energy Corporation
PGH
$8K ﹤0.01%
11,159
OPGN
3967
DELISTED
OpGen, Inc
OPGN
0
CYTO
3968
DELISTED
Altamira Therapeutics Ltd
CYTO
0
NVCN
3969
DELISTED
Neovasc Inc.
NVCN
-1
Closed -$27.5K
RHE
3970
DELISTED
Regional Health Properties, Inc.
RHE
$6K ﹤0.01%
3,380
RLOG
3971
DELISTED
Rand Logistics, Inc.
RLOG
$6K ﹤0.01%
43,254
TRNX
3972
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$4K ﹤0.01%
10
JAGX icon
3973
Jaguar Health
JAGX
$4.76M
0
IMUC
3974
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$3K ﹤0.01%
10,995
QCLS
3975
Q/C Technologies Inc
QCLS
$21.1M
0

Similar funds

Geode Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Geode Capital Management held 4,142 positions worth $294B, up 8.7% from $271B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Geode Capital Management's Q4 2017 filing shows 98 new, 2,556 increased, 827 reduced and 120 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M. The largest sale was CR Bard Inc., an estimated $243M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M.
  • Geode Capital Management added most to Apple in Q4 2017, an estimated $227M increase.
  • Geode Capital Management's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $23.7M.
  • Geode Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $243M.
  • Geode Capital Management's ten largest holdings make up 17% of its $294B portfolio in Q4 2017.
  • Geode Capital Management opened 98 new positions and closed 120 in Q4 2017.
  • Geode Capital Management's portfolio value rose 8.7% quarter-over-quarter to $294B.

Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.